{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T18:56:20Z","timestamp":1792090580205,"version":"4.4.0"},"reference-count":55,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Oradea, Oradea, Romania"},{"id":[{"id":"https:\/\/ror.org\/00wzhv093","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: Discrepancies are frequently observed between liver steatosis grading assessed by conventional B-mode ultrasonography and vibration-controlled transient elastography (VCTE) with controlled attenuation parameter (CAP). This study aimed to identify factors associated with these differences and to evaluate whether the two imaging methods provide comparable steatosis classifications. Methods: We conducted a retrospective cross-sectional observational study including 130 hospitalized patients evaluated over a two-year period who underwent laboratory testing, abdominal ultrasonography, and transient elastography. The analyzed variables included demographic characteristics, nutritional status, comorbidities, and biochemical parameters such as alanine aminotransferase (ALAT), total cholesterol, triglycerides, gamma-glutamyl transferase (GGT), and the fibrosis-4 index (FIB-4). Patients were classified into two groups: concordant steatosis grading between the two methods (n = 61) and discordant results (n = 69). Results: Concordant steatosis grading was more frequently observed in patients with serum total cholesterol &gt; 200 mg\/dL (45.9%) and FIB-4 values between 1.45\u20133.25 (44.2%). A trend toward higher concordance was also observed in patients with elevated triglycerides. In contrast, viral liver disease was significantly associated with discordant results (26.2%). Higher fibrosis stages assessed by VCTE (F \u2265 2) and FIB-4 values &gt; 3.25 showed a non-significant trend toward discordance. Conclusions: Several clinical and biochemical factors influence the agreement between ultrasound and VCTE-based CAP in the assessment of hepatic steatosis. Elevated cholesterol and intermediate FIB-4 values were associated with concordant results, whereas viral liver disease was associated with discordance between the two imaging modalities.<\/jats:p>","DOI":"10.3390\/diagnostics16081188","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:05:36Z","timestamp":1776348336000},"page":"1188","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Discordance Between Conventional Ultrasound and Transient Elastography in Hepatic Steatosis Assessment: Clinical Factors Associated with Discrepant Findings"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3603-8070","authenticated-orcid":false,"given":"Mihaela Cristina","family":"Brisc","sequence":"first","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7514-172X","authenticated-orcid":false,"given":"Elena Emilia","family":"Babe\u0219","sequence":"additional","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina Florina","family":"C\u0103lug\u0103r-\u0218olea","sequence":"additional","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Bota","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Gastroenterology (IMuG), Division of Hepatology, Endocrinology, Rheumatology, Nephrology and Emergency Medicine (ZAE), Centralized Endoscopy Service, Klinikum Klagenfurt am W\u00f6rthersee, 9020 Klagenfurt, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8901-8271","authenticated-orcid":false,"given":"Laura","family":"Maghiar","sequence":"additional","affiliation":[{"name":"Department of Psycho-Neurosciences and Rehabilitation, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian Mihai","family":"Brisc","sequence":"additional","affiliation":[{"name":"Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciprian","family":"Brisc","sequence":"additional","affiliation":[{"name":"Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, 410087 Oradea, Romania"},{"name":"Department of Medical Disciplines, Faculty of Medicine and Pharmacy, University of Oradea, 410073 Oradea, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,16]]},"reference":[{"key":"ref_1","first-page":"167","article-title":"Pathogenesis and Prevention of Hepatic Steatosis","volume":"11","author":"Nassir","year":"2015","journal-title":"Gastroenterol. Hepatol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3748\/wjg.v21.i14.4103","article-title":"Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: An open question","volume":"21","author":"Streba","year":"2015","journal-title":"World J. Gastroenterol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Nassir, F. (2022). NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules, 12.","DOI":"10.3390\/biom12060824"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-pathol-121808-102132","article-title":"Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis","volume":"5","author":"Tiniakos","year":"2010","journal-title":"Annu. Rev. Pathol. Mech. Dis."},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Brunt, E.M. (2016). Nonalcoholic Fatty Liver Disease: Pros and Cons of Histologic Systems of Evaluation. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010097"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0002-9343(99)00271-5","article-title":"Association of nonalcoholic fatty liver disease with insulin resistance","volume":"107","author":"Marchesini","year":"1999","journal-title":"Am. J. Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/diabetes.50.8.1844","article-title":"Nonalcoholic fatty liver disease: A feature of the metabolic syndrome","volume":"50","author":"Marchesini","year":"2001","journal-title":"Diabetes"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1111\/j.1440-1746.2006.04698.x","article-title":"Significant correlations between severe fatty liver and risk factors for metabolic syndrome","volume":"22","author":"Hsiao","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/j.1464-5491.2005.01582.x","article-title":"Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults","volume":"22","author":"Jimba","year":"2005","journal-title":"Diabet. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13098-022-00811-2","article-title":"Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease","volume":"14","author":"Han","year":"2022","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2147\/DMSO.S189544","article-title":"The fatty liver index, a simple and useful predictor of metabolic syndrome: Analysis of the Korea National Health and Nutrition Examination Survey 2010\u20132011","volume":"12","author":"Khang","year":"2019","journal-title":"Diabetes Metab. Syndr. Obes. Targets Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4368","DOI":"10.4103\/jfmpc.jfmpc_58_22","article-title":"A study of non-alcoholic fatty liver disease-liver fat score in overweight and obese individuals","volume":"11","author":"Koneru","year":"2022","journal-title":"J. Fam. Med. Prim. Care"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4277","DOI":"10.7150\/thno.40249","article-title":"Quantitative ultrasound approaches for diagnosis and monitoring hepatic steatosis in nonalcoholic fatty liver disease","volume":"10","author":"Pirmoazen","year":"2020","journal-title":"Theranostics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ultrasmedbio.2010.07.005","article-title":"Controlled Attenuation Parameter (CAP): A Novel VCTETM Guided Ultrasonic Attenuation Measurement for the Evaluation of Hepatic Steatosis: Preliminary Study and Validation in a Cohort of Patients with Chronic Liver Disease from Various Causes","volume":"36","author":"Sasso","year":"2010","journal-title":"Ultrasound Med. Biol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Karlas, T., Petroff, D., Garnov, N., B\u00f6hm, S., Tenckhoff, H., Wittekind, C., Wiese, M., Schiefke, I., Linder, N., and Schaudinn, A. (2014). Non-invasive assessment of hepatic steatosis in patients with NAFLD using controlled attenuation parameter and 1H-MR spectroscopy. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0091987"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1111\/jgh.12557","article-title":"Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease","volume":"29","author":"Chan","year":"2014","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/jgh.13219","article-title":"Controlled attenuation parameter for the diagnosis of steatosis in non-alcoholic fatty liver disease","volume":"31","author":"Wong","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Lee, H.W., Park, S.Y., Kim, S.U., Jang, J.Y., Park, H., Kim, J.K., Lee, C.K., Chon, Y.E., and Han, K.-H. (2016). Discrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0157358"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/2050640616646528","article-title":"Controlled attenuation parameter using the FibroScan\u00ae XL probe for quantification of hepatic steatosis for non-alcoholic fatty liver disease in an Asian population","volume":"5","author":"Chan","year":"2017","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1053\/j.gastro.2016.10.026","article-title":"Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients with Biopsy-Proven Nonalcoholic Fatty Liver Disease","volume":"152","author":"Park","year":"2017","journal-title":"Gastroenterology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1111\/jgh.14150","article-title":"Can the same controlled attenuation parameter cut-offs be used for M and XL probes for diagnosing hepatic steatosis?","volume":"33","author":"Chan","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1148\/radiol.2017162931","article-title":"MR Spectroscopy\u2013derived Proton Density Fat Fraction Is Superior to Controlled Attenuation Parameter for Detecting and Grading Hepatic Steatosis","volume":"286","author":"Runge","year":"2017","journal-title":"Radiology"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1053\/j.gastro.2015.11.048","article-title":"Magnetic Resonance Imaging More Accurately Classifies Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease Than Transient Elastography","volume":"150","author":"Imajo","year":"2016","journal-title":"Gastroenterology"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.29639","article-title":"Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis","volume":"67","author":"Caussy","year":"2018","journal-title":"Hepatology"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ultrasmedbio.2015.08.008","article-title":"Liver Steatosis Assessed by Controlled Attenuation Parameter (CAP) Measured with the XL Probe of the FibroScan: A Pilot Study Assessing Diagnostic Accuracy","volume":"42","author":"Sasso","year":"2016","journal-title":"Ultrasound Med. Biol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling","year":"2006","journal-title":"Hepatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","article-title":"Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: A meta-analysis","volume":"54","author":"Hernaez","year":"2011","journal-title":"Hepatology"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.dld.2006.03.021","article-title":"The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis","volume":"38","author":"Palmentieri","year":"2006","journal-title":"Dig. Liver Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/gast.2002.35354","article-title":"The utility of radiological imaging in nonalcoholic fatty liver disease","volume":"123","author":"Saadeh","year":"2002","journal-title":"Gastroenterology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"W320","DOI":"10.2214\/AJR.07.2123","article-title":"Interobserver and intraobserver variability in the sonographic assessment of fatty liver","volume":"189","author":"Strauss","year":"2007","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Hepburn, M.J., Vos, J.A., Fillman, E.P., and Lawitz, E.J. (2005). The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: A retrospective observational study. BMC Gastroenterol., 5.","DOI":"10.1186\/1471-230X-5-14"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.14366\/usg.21076","article-title":"Accuracy of the ultrasound attenuation coefficient for the evaluation of hepatic steatosis: A systematic review and meta-analysis of prospective studies","volume":"41","author":"Jang","year":"2022","journal-title":"Ultrasonography"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.jhep.2013.12.018","article-title":"Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations","volume":"60","author":"Vergniol","year":"2014","journal-title":"J. Hepatol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ultrasmedbio.2012.09.017","article-title":"Factors Which Influence the Accuracy of Acoustic Radiation Force Impulse (ARFI) Elastography for the Diagnosis of Liver Fibrosis in Patients with Chronic Hepatitis C","volume":"39","author":"Bota","year":"2013","journal-title":"Ultrasound Med. Biol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"634","DOI":"10.5152\/tjg.2024.23531","article-title":"Liver stiffness and steatosis measurements with iLivTouch and FibroScan: A comparative study","volume":"35","author":"Duman","year":"2024","journal-title":"Turk. J. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.amjms.2024.01.022","article-title":"ALT poorly predicts Nonalcoholic Fatty Liver Disease (NAFLD) and liver fibrosis as determined by vibration-controlled transient elastography in adult National Health and Nutrition Examination Survey 2017-2018","volume":"367","author":"Condon","year":"2024","journal-title":"Am. J. Med. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"European Association for the Study of the Liver (2021). EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity prognosis-2021 update. J. Hepatol., 75, 659\u2013689.","DOI":"10.1016\/j.jhep.2021.05.025"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10396-024-01473-5","article-title":"Diagnostic performance of two-dimensional shear wave elastography and attenuation imaging for fibrosis and steatosis assessment in chronic liver disease","volume":"52","author":"Kobayashi","year":"2025","journal-title":"J. Med. Ultrason."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wang, M., Tang, S., Li, G., Huang, Z., Mo, S., Yang, K., Chen, J., Du, B., Xu, J., and Ding, Z. (2024). Comparative study of ultrasound attenuation analysis and controlled attenuation parameter in the diagnosis and grading of liver steatosis in non-alcoholic fatty liver disease patients. BMC Gastroenterol., 24.","DOI":"10.1186\/s12876-024-03160-8"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12020-022-03157-x","article-title":"Ultrasound and FibroScan\u00ae Controlled Attenuation Parameter in patients with MAFLD: Head-to-head comparison in assessing liver steatosis","volume":"78","author":"Salmi","year":"2022","journal-title":"Endocrine"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Villani, R., Lupo, P., Sangineto, M., Romano, A.D., and Serviddio, G. (2023). Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary. Diagnostics, 13.","DOI":"10.3390\/diagnostics13071236"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"6662760","DOI":"10.1155\/2021\/6662760","article-title":"Controlled Attenuation Parameter for Quantification of Steatosis: Which Cut-Offs to Use?","volume":"2021","author":"Sirli","year":"2021","journal-title":"Can. J. Gastroenterol. Hepatol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Bozic, D., Podrug, K., Mikolasevic, I., and Grgurevic, I. (2022). Ultrasound Methods for the Assessment of Liver Steatosis: A Critical Appraisal. Diagnostics, 12.","DOI":"10.3390\/diagnostics12102287"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1002\/jum.16242","article-title":"Liver Fat Quantification with Ultrasound: Depth Dependence of Attenuation Coefficient","volume":"42","author":"Ferraioli","year":"2023","journal-title":"J. Ultrasound Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5937\/jomb0-24689","article-title":"Clinical relevance of lipid panel and aminotransferases in the context of hepatic steatosis and fibrosis as measured by transient elastography (FibroScan\u00ae)","volume":"40","author":"Montalvo","year":"2021","journal-title":"J. Med. Biochem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12944-017-0537-z","article-title":"Isolated hypercholesterolemia leads to steatosis in the liver without affecting the pancreas","volume":"16","author":"Csonka","year":"2017","journal-title":"Lipids Health Dis."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Sporea, I., Mare, R., Popescu, A., Nistorescu, S., Baldea, V., Sirli, R., Braha, A., Sima, A., Timar, R., and Lupusoru, R. (2020). Screening for Liver Fibrosis and Steatosis in a Large Cohort of Patients with Type 2 Diabetes Using Vibration Controlled Transient Elastography and Controlled Attenuation Parameter in a Single-Center Real-Life Experience. J. Clin. Med., 9.","DOI":"10.3390\/jcm9041032"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jhep.2010.11.021","article-title":"Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease","volume":"55","author":"Yeh","year":"2011","journal-title":"J. Hepatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/br.2014.309","article-title":"Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes","volume":"2","author":"Tomizawa","year":"2014","journal-title":"Biomed. Rep."},{"key":"ref_50","first-page":"1453","article-title":"Degree of Discordance Between FIB-4 and Transient Elastography: An Application of Current Guidelines on General Population Cohort","volume":"22","author":"Chang","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol. Off. Clin. Pract. J. Am. Gastroenterol. Assoc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"19275","DOI":"10.1038\/s41598-021-98776-1","article-title":"Combination of FIB-4 with ultrasound surface nodularity or elastography as predictors of histologic advanced liver fibrosis in chronic liver disease","volume":"11","author":"Moini","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e40214","DOI":"10.1097\/MD.0000000000040214","article-title":"Diagnostic role of the fibrosis-4 index and nonalcoholic fatty liver disease fibrosis score as a noninvasive tool for liver fibrosis scoring","volume":"103","author":"Chen","year":"2024","journal-title":"Medicine"},{"key":"ref_53","first-page":"e29445","article-title":"Accuracy of Ultrasound Elastography and Fibrosis-4 Index (FIB-4) in Ruling Out Cirrhosis in Obese Non-Alcoholic Fatty Liver Disease (NAFLD) Patients","volume":"14","author":"Damjanovska","year":"2022","journal-title":"Cureus"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/apt.17564","article-title":"Clinical and histologic factors associated with discordance between steatosis grade derived from histology vs. MRI-PDFF in NAFLD","volume":"58","author":"Kim","year":"2023","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"15557","DOI":"10.1038\/s41598-023-42422-5","article-title":"Discordance diagnosis between B-mode ultrasonography and MRI proton density fat fraction for fatty liver","volume":"13","author":"Lee","year":"2023","journal-title":"Sci. Rep."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/8\/1188\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:14:07Z","timestamp":1776348847000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/8\/1188"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,16]]},"references-count":55,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["diagnostics16081188"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16081188","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,16]]}}}